Back
Rhythm Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
79
RYTM
Rhythm Pharmaceuticals
Last Price:
59.30
Seasonality Move:
6.59%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- The current trend is moderately bullish and RYTM is experiencing slight selling pressure.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.44 | Sell |
| 20-day SMA: | 56.51 | Buy |
| 50-day SMA: | 52.91 | Buy |
| 200-day SMA: | 45.68 | Buy |
| 8-day EMA: | 59.46 | Sell |
| 20-day EMA: | 57.38 | Buy |
| 50-day EMA: | 53.68 | Buy |
| 200-day EMA: | 45.82 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.51 | Buy |
| Relative Strength Index (14 RSI): | 56.6 | Buy |
| Chaikin Money Flow: | -16945 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.08 - 61.46) | Buy |
| Bollinger Bands (100): | (44.8 - 55.02) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 59.36 while RYTM 8-day simple moving average is 60.44, which is a Sell signal.
- The stock price of RYTM is 59.36 while Rhythm Pharmaceuticals 20-day SMA is 56.51, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day simple moving average is 52.91 while RYTM share price is 59.36, making it a Buy technically.
- RYTM stock price is 59.36 and Rhythm Pharmaceuticals 200-day simple moving average is 45.68, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
79
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a Buy
The current Rhythm Pharmaceuticals [RYTM] share price is $59.36. The Score for RYTM is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.65B
Price in USD:
59.36
Share Volume:
386.9K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
68.58
52-Week Low:
31.53
Buy
79
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?
The Rhythm Pharmaceuticals stock price is 59.36 USD today. -
Will RYTM stock go up or go down?
Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rhythm Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 59.36 while RYTM 8-day exponential moving average is 59.46, which is a Sell signal.
- The stock price of RYTM is 59.36 while Rhythm Pharmaceuticals 20-day EMA is 57.38, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day exponential moving average is 53.68 while RYTM share price is 59.36, making it a Buy technically.
- RYTM stock price is 59.36 and Rhythm Pharmaceuticals 200-day simple moving average is 45.82, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
- RYTM Moving Average Covergence Divergence (MACD) indicator is 2.51, suggesting Rhythm Pharmaceuticals is a Buy
- Rhythm Pharmaceuticals Relative Strength Index (RSI) is 56.6, which suggest Rhythm Pharmaceuticals is overbought
- The Bollinger Bands (25) for Rhythm Pharmaceuticals is (49.08 - 61.46), which suggest Rhythm Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Rhythm Pharmaceuticals is (44.8 - 55.02), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.